|
Re: The Rubicon or the Jordan?
|
2
|
Resverlogix Corp.
|
Apr 10, 2018 04:59PM
|
|
Re: Apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation
|
2
|
Resverlogix Corp.
|
Jun 07, 2018 09:08AM
|
|
Re: FXR and liver transaminase related adverse events
|
2
|
Resverlogix Corp.
|
Oct 03, 2018 11:47AM
|
|
Re: AACR 2019
|
2
|
Zenith Epigenetics
|
Feb 28, 2019 11:39AM
|
|
Re: Equity financing
|
2
|
Zenith Epigenetics
|
Jun 07, 2018 09:14AM
|
|
Re: RVX in the next 5 weeks
|
2
|
Resverlogix Corp.
|
Aug 15, 2016 10:50AM
|
|
Re: At least RVX has a shorter trial timeline than ESPR
|
2
|
Resverlogix Corp.
|
May 05, 2016 12:54PM
|
|
Re: Is this new?
|
2
|
Resverlogix Corp.
|
May 30, 2019 02:08PM
|
|
Aducanumab, Alzheimer's and the application of Mtfp
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 03, 2016 01:08PM
|
|
Re: New MD&A posted
|
2
|
Resverlogix Corp.
|
Dec 18, 2019 08:23PM
|
|
Re: I wonder...
|
2
|
Resverlogix Corp.
|
Jan 23, 2020 01:15PM
|
|
Re: June 30-July 02, 2016: 9th World Drug Delivery Summit
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 06, 2016 09:10PM
|
|
Re: News - August 29
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 30, 2016 12:10AM
|
|
Re: Timelines for notice of meeting for AGMs
|
2
|
Resverlogix Corp.
|
Sep 26, 2016 11:28AM
|
|
Another application/indicati... for the compound libraries
|
2
|
Resverlogix Corp.
|
May 19, 2017 12:01PM
|
|
Re: Danish cancer breakthrough
|
2
|
Resverlogix Corp.
|
Oct 15, 2015 11:01AM
|
|
Denali/Sirion deal to get AAVs across the BBB
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 09, 2019 01:34PM
|
|
Re: ...somebody’s having fun...
|
2
|
Resverlogix Corp.
|
Feb 21, 2019 08:19PM
|
|
Re: Oncology
|
2
|
Resverlogix Corp.
|
Dec 10, 2019 11:18PM
|
|
Re: Presentation available
|
2
|
Resverlogix Corp.
|
Jun 10, 2020 11:33AM
|
